JamtekiTM is the second biosimilar developed under this partnership that receives marketing authorization in Canada. The currently approved presentations of JamtekiTM are a 45mg/0.5mL pre-filled ...

A new generic option of Enzalutamide, an oncology medication used for the treatment of certain stages of prostate cancer 2. It is an orally administered antiandrogen. JAMP Pharma Group is launching Pr ...

JAMP Pharma's new head office on Boucherville, Québec. (c) Bénédicte Brocard (CNW Group/Fonds de solidarité FTQ) Boucherville, Quebec – October 25, 2016 — JAMP Pharma, a Boucherville based generic ...

JAMP Pharma Group launches PrPexegra®, a biosimilar alternative to the reference product PrNeulasta® (commercialized in Canada by Amgen Canada Inc.). JAMP Pharma Group also launches PrFilra®, a ...

Alvotech, a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, and JAMP Pharma Group (JAMP Pharma), a Canadian owned pharmaceutical ...

Add Yahoo as a preferred source to see more of our stories on Google. A monitor is seen during a heart catheterization. A prescription medication to treat congestive heart failure is being recalled in ...

Alvotech, a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, and the JAMP Pharma Group (JAMP Pharma), a Canadian owned ...

PrJamtekiTM is the second biosimilar developed under this partnership that receives marketing authorization in Canada. REYKJAVIK, Iceland and BOUCHERVILLE, Quebec, Nov. 14, 2023 (GLOBE NEWSWIRE) -- ...

The audio version of this article is generated by AI-based technology. Mispronunciations can occur. We are working with our partners to continually review and improve the results. A monitor is seen ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, and JAMP Pharma Group (“JAMP Pharma”), a Canadian ...